Search

everythinglearnresearchcommunity

for

Search:↓

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

Treat active lichen planopilaris early to prevent permanent hair loss.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

The LTF gene may help predict and manage nonspecific orbital inflammation.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

JAK inhibitors show promise for treating various skin diseases.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Activating TRPMLs helps human cells important for hair growth and increases hair growth in mice.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

The new nanoparticles could improve melanoma treatment by working better than current options.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Retinoids may help treat lupus nephritis and reduce steroid use.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

A new compound effectively inhibits human 5α-reductase 1.

Certain drugs can cause eyelid inflammation, so doctors should monitor and educate patients on eyelid care.